248 related articles for article (PubMed ID: 27055904)
1. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
[TBL] [Abstract][Full Text] [Related]
2. P2Y
Albayati S; Vemulapalli H; Tsygankov AY; Liverani E
J Leukoc Biol; 2021 Jul; 110(1):141-153. PubMed ID: 33242353
[TBL] [Abstract][Full Text] [Related]
3. P2Y
Mansour A; Bachelot-Loza C; Nesseler N; Gaussem P; Gouin-Thibault I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092903
[TBL] [Abstract][Full Text] [Related]
4. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
[TBL] [Abstract][Full Text] [Related]
5. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y
Amison RT; Arnold S; O'Shaughnessy BG; Cleary SJ; Ofoedu J; Idzko M; Page CP; Pitchford SC
Pulm Pharmacol Ther; 2017 Aug; 45():62-68. PubMed ID: 28487256
[TBL] [Abstract][Full Text] [Related]
7. NOD2-mediated P2Y
Zhong H; Waresi M; Zhang W; Han L; Zhao Y; Chen Y; Zhou P; Chang L; Pan G; Wu B; Li J; Zhang S; Shi H; Luo X; Gao W; Qi Z; Ding Z
Biochem Pharmacol; 2021 Dec; 194():114822. PubMed ID: 34748820
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel: interactions with the P2Y12 receptor and clinical relevance.
Dorsam RT; Murugappan S; Ding Z; Kunapuli SP
Hematology; 2003 Dec; 8(6):359-65. PubMed ID: 14668029
[No Abstract] [Full Text] [Related]
9. Clopidogrel reduces lipopolysaccharide-induced inflammation and neutrophil-platelet aggregates in an experimental endotoxemic model.
Wang XL; Deng HF; Li T; Miao SY; Xiao ZH; Liu MD; Liu K; Xiao XZ
J Biochem Mol Toxicol; 2019 Apr; 33(4):e22279. PubMed ID: 30537341
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis.
Garcia AE; Mada SR; Rico MC; Dela Cadena RA; Kunapuli SP
PLoS One; 2011; 6(10):e26035. PubMed ID: 22028806
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
[TBL] [Abstract][Full Text] [Related]
12. Sepsis favors high-on-clopidogrel platelet reactivity.
Akinosoglou K; Perperis A; Theodoraki S; Alexopoulos D; Gogos C
Platelets; 2018 Jan; 29(1):76-78. PubMed ID: 28635374
[TBL] [Abstract][Full Text] [Related]
13. Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.
Thomas MR; Outteridge SN; Ajjan RA; Phoenix F; Sangha GK; Faulkner RE; Ecob R; Judge HM; Khan H; West LE; Dockrell DH; Sabroe I; Storey RF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2562-70. PubMed ID: 26515417
[TBL] [Abstract][Full Text] [Related]
14. A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y
Makkawi M; Howells D; Wright MD; Jackson DE
Thromb Res; 2018 Jan; 161():12-21. PubMed ID: 29178985
[TBL] [Abstract][Full Text] [Related]
15. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
[TBL] [Abstract][Full Text] [Related]
16. Platelet P2Y
Amoafo EB; Entsie P; Kang Y; Canobbio I; Liverani E
Br J Pharmacol; 2024 Feb; 181(4):532-546. PubMed ID: 37525937
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis.
Rahman M; Gustafsson D; Wang Y; Thorlacius H; Braun OÖ
Platelets; 2014; 25(4):257-63. PubMed ID: 23855479
[TBL] [Abstract][Full Text] [Related]
18. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
Schrottmaier WC; Kral JB; Badrnya S; Assinger A
Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
[TBL] [Abstract][Full Text] [Related]
19. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.
Polanowska-Grabowska R; Wallace K; Field JJ; Chen L; Marshall MA; Figler R; Gear AR; Linden J
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2392-9. PubMed ID: 21071696
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
